Ex parte BECKNER et al. - Page 10




              Appeal No. 1997-2372                                                                                         
              Application 08/083,945                                                                                       



              enablement for recovering heparin from solution which would be implied in a method of                        
              purification.  Examiner’s answer, page 5, lines 13-21.                                                       
                     Appellants respond to this argument with rebuttal evidence showing that ionic                         
              bonds form between heparin and heparin binding proteins and that such bonds are readily                      
              dissociated under mild conditions by raising the salt concentration of the medium.  Reply                    
              Brief, page 6 and Exhibits A-K.  For this reason, appellants submit  that one of ordinary                    
              skill in the art would not expect to encounter any difficulties in effecting elution if a heparin            
              affinity column were used for purification.  Reply Brief, page 6.                                            
                     In our view, the examiner has failed to present a sufficient factual basis or evidence                
              to rebut the argument and evidence presented by appellants.  Therefore, we disagree with                     
              the examiner with respect to the examiner’s position of lack of enablement of  claims 36                     
              and 37, and find these claims to be enabled by the present specification.  It would appear                   
              that the specification reasonably describes how to make and how to use peptides with                         
              binding affinity to heparin (claim 37), and a specific peptide (SEQ ID NO:7) with binding                    
              affinity to heparin (Claim 36), in a manner sufficient for those of ordinary skill in the art to             
              practice the claimed invention within the scope of these claims.  We agree with appellants                   
              that the examiner has failed to establish that the polypeptides of claims 36 and 37 could                    
              not be used in affinity purification of heparin.                                                             



                                                            10                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007